This week, Canada’s main stock index, the TSX , hit a record high thanks to gains in technology and bank stocks. What the “Buzz” Our Bullboards have up to 2 million pageviews a day. Get the inside scoop on conv...
Trevor Abes
|
December 4, 2024
|
Being a technical trader means we attempt to identify opportunities in and market, symbol, or sector based on technical indicators, price patterns, advanced price theory/modeling, and much more. We don’t particularly care if the opportunity is a bullish break...
Chris Vermeulen
|
June 22, 2020
|
TOMI Environmental Solutions Inc.'s (TOMZ:OTCQB) products kill pathogens—safely and effectively. Not just the coronavirus: Ebola, MERS, C. diff spores, sepsis, norovirus, anthrax, Staphylococcus, MRSA, Legionnaire's and Zika. The kill list also includes food borne illnes...
Streetwise Reports
|
February 19, 2020
|
In a September report, the World Gold Council (WGC) pointed out that some investors are underexposed to gold. The gist of the study is that investors may assume they have adequate exposure to gold because they’re invested in a fund that tracks a broad-ba...
Frank Holmes
|
November 4, 2019
|
Innovative technologies and social trends often determine the positive performance of an investment portfolio. The biggest challenge, however, is to recognize the development of a new need in society at the right time and to benefit from it with the right companies. But unders...
Mario Hose
|
April 28, 2020
|
In recent months, the World Gold Council released a few interesting reports. What can we learn from the publications? We’ll then supplement it with the view of the Fed policies. Will gold like the message? Gold Demand Trends Q2 2019 On August 1, the WG...
Arkadiusz Sieron
|
August 27, 2019
|
Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...
Streetwise Reports
|
September 12, 2019
|
Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports
|
September 24, 2019
|
American manufacturers are scoring ever deeper recessionary readings. We haven’t seen this bad an ISM Manufacturing reading in quite a while. Can it take the broader economy with it? And what about gold – when exactly will it get its shine? ISM Manufacturing...
Arkadiusz Sieron
|
October 3, 2019
|
As a technical trader, one has to really learn to appreciate when a trade “reloads” for another move higher. Much like the Gold base/bottom in April 2019 below $1300 that we called back in October 2018. When a trend confirms and we can see the potential...
Chris Vermeulen
|
October 7, 2019
|